| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
Department of Biochemistry [K. N., J. G., C-X. G., S. N., T. K., K. H., N. T.], Department of Molecular Biochemistry and Clinical Investigations [K. N., E. M., C-X. G.], Department of Molecular Therapeutics, Division of Molecular Therapy Science [K. N., N. H.], Department of Internal Medicine and Therapeutics [K. N., M. H.], and Department of General Medicine [A. K.], Osaka University, Graduate School of Medicine, Osaka, Japan; Departments of Gastroenterology [K. S., H. Y.], Surgery [K. Y.], and Pathology [K. K.], Osaka Rosai Hospital, Osaka, 565-0871, Japan; Department of Experimental Medicine, University of Genova and Center of Excellence for Biomedical Research, 16132 Genova, Italy [M. T.], and Department of Molecular Genetics, Kochi Medical School, Kochi 783-8505, Japan [K. H.]
The levels of fucosylated glycoproteins in various cancers and inflammatory processes have been a subject of intense study. The level of fucosyltransferases and intracellular GDP-L-fucose, a sugar nucleotide and a common donor substrate for all fucosyltransferases, may regulate the level of fucosylated glycoproteins. This study reports on the determination of GDP-L-fucose levels in human hepatocellular carcinoma (HCC) and surrounding tissues, using a recently established high-throughput assay system. Levels of GDP-L-fucose in HCC tissues were significantly increased compared with adjacent nontumor tissues or normal livers. The mean ± SD for GDP-L-fucose level was 3.6 ± 0.2 µmol/mg in control liver, 4.6 ± 0.9 µmol/mg in adjacent noninvolved liver tissues (chronic hepatitis, 4.4 ± 0.7 µmol/mg; liver cirrhosis, 4.8 ± 0.9 µmol/mg), and 7.1 ± 2.5 µmol/mg in HCC tissues. The level of GDP-L-fucose in HCC decreased in proportion with tumor size (r = -0.675, P = 0.0002). When expression of the series of genes responsible for GDP-L-fucose synthesis was investigated, the gene expression of FX was found to be increased in 70% (7 of 10) of the HCC tissues examined compared with that in their surrounding tissues. The levels of GDP-L-fucose were positively correlated with the expression of FX mRNA (r = 0.599, P = 0.0074). The levels of FX gene expression in some human hepatoma and hepatocyte cell lines were determined. FX mRNA production was strongly increased in HepG2 and Chang liver, moderately increased in Hep3B and HLF, and, in HLE, was similar to that of a normal human liver tissue. To investigate the effect of GDP-L-fucose on core fucosylation, FX cDNA was transfected into Hep3B cells, which express a relatively low level of GDP-L-fucose:N-acetyl-ß-D-glucosaminide
1-6 fucosyltransferase (
1-6 FucT) and FX mRNA. Transfection of this gene caused an increase in GDP-L-fucose levels as well as the extent of fucosylation on glycoproteins, including
-fetoprotein, as judged by reactivity to lectins. Collectively, the results herein suggest that the high level of fucosylation in HCC is dependent on a high expression of FX followed by increases in GDP-L-fucose, as well as an enhancement in
1-6 FucT expression. Thus, an elevation in GDP-L-fucose levels and the up-regulation of FX expression represent potential markers for HCC.
This article has been cited by other articles:
![]() |
E. Miyoshi, K. Moriwaki, and T. Nakagawa Biological Function of Fucosylation in Cancer Biology J. Biochem., June 1, 2008; 143(6): 725 - 729. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Moriwaki, K. Noda, T. Nakagawa, M. Asahi, H. Yoshihara, N. Taniguchi, N. Hayashi, and E. Miyoshi A High Expression of GDP-Fucose Transporter in Hepatocellular Carcinoma is a Key Factor for Increases in Fucosylation Glycobiology, December 1, 2007; 17(12): 1311 - 1320. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matsumura, K. Higashida, H. Ishida, Y. Hata, K. Yamamoto, M. Shigeta, Y. Mizuno-Horikawa, X. Wang, E. Miyoshi, J. Gu, et al. Carbohydrate Binding Specificity of a Fucose-specific Lectin from Aspergillus oryzae: A NOVEL PROBE FOR CORE FUCOSE J. Biol. Chem., May 25, 2007; 282(21): 15700 - 15708. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Barrabes, L. Pages-Pons, C. M. Radcliffe, G. Tabares, E. Fort, L. Royle, D. J. Harvey, M. Moenner, R. A. Dwek, P. M. Rudd, et al. Glycosylation of serum ribonuclease 1 indicates a major endothelial origin and reveals an increase in core fucosylation in pancreatic cancer Glycobiology, April 1, 2007; 17(4): 388 - 400. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sasamura, H. O. Ishikawa, N. Sasaki, S. Higashi, M. Kanai, S. Nakao, T. Ayukawa, T. Aigaki, K. Noda, E. Miyoshi, et al. The O-fucosyltransferase O-fut1 is an extracellular component that is essential for the constitutive endocytic trafficking of Notch in Drosophila Development, April 1, 2007; 134(7): 1347 - 1356. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhao, S. Itoh, X. Wang, T. Isaji, E. Miyoshi, Y. Kariya, K. Miyazaki, N. Kawasaki, N. Taniguchi, and J. Gu Deletion of Core Fucosylation on {alpha}3beta1 Integrin Down-regulates Its Functions J. Biol. Chem., December 15, 2006; 281(50): 38343 - 38350. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ma, J. L. Simala-Grant, and D. E. Taylor Fucosylation in prokaryotes and eukaryotes Glycobiology, December 1, 2006; 16(12): 158R - 184R. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakagawa, N. Uozumi, M. Nakano, Y. Mizuno-Horikawa, N. Okuyama, T. Taguchi, J. Gu, A. Kondo, N. Taniguchi, and E. Miyoshi Fucosylation of N-Glycans Regulates the Secretion of Hepatic Glycoproteins into Bile Ducts J. Biol. Chem., October 6, 2006; 281(40): 29797 - 29806. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, J. Gu, H. Ihara, E. Miyoshi, K. Honke, and N. Taniguchi Core Fucosylation Regulates Epidermal Growth Factor Receptor-mediated Intracellular Signaling J. Biol. Chem., February 3, 2006; 281(5): 2572 - 2577. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, S. Inoue, J. Gu, E. Miyoshi, K. Noda, W. Li, Y. Mizuno-Horikawa, M. Nakano, M. Asahi, M. Takahashi, et al. From The Cover: Dysregulation of TGF-{beta}1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice PNAS, November 1, 2005; 102(44): 15791 - 15796. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sturla, F. Fruscione, K. Noda, E. Miyoshi, N. Taniguchi, P. Contini, and M. Tonetti Core fucosylation of N-linked glycans in leukocyte adhesion deficiency/congenital disorder of glycosylation IIc fibroblasts Glycobiology, October 1, 2005; 15(10): 924 - 934. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. F. Aoki, H. Mamitsuka, T. Akutsu, and M. Kanehisa A score matrix to reveal the hidden links in glycans Bioinformatics, April 15, 2005; 21(8): 1457 - 1463. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Block, M. A. Comunale, M. Lowman, L. F. Steel, P. R. Romano, C. Fimmel, B. C. Tennant, W. T. London, A. A. Evans, B. S. Blumberg, et al. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans PNAS, January 18, 2005; 102(3): 779 - 784. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zipin, M. Israeli-Amit, T. Meshel, O. Sagi-Assif, I. Yron, V. Lifshitz, E. Bacharach, N. I. Smorodinsky, A. Many, P. A. Czernilofsky, et al. Tumor-Microenvironment Interactions: The Fucose-Generating FX Enzyme Controls Adhesive Properties of Colorectal Cancer Cells Cancer Res., September 15, 2004; 64(18): 6571 - 6578. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-S. Ryu, C. Kim, I. Kim, S. Yoo, B.-S. Choi, and C. Park NMR Application Probes a Novel and Ubiquitous Family of Enzymes That Alter Monosaccharide Configuration J. Biol. Chem., June 11, 2004; 279(24): 25544 - 25548. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |